$60.8M
51-100
BIORCHESTRA is a biotech company pioneering RNA-based therapeutics aimed at neuroinflammatory diseases. By shifting the focus from merely alleviating symptoms to delivering fundamental cures, BIORCHESTRA is transforming the therapeutic landscape, offering innovative solutions that target the root causes of these complex conditions.
National Rank
Share
Loading...
In South Korea
out of startups
City Rank
Share
2nd
In Daejeon
out of 24 startups
National Rank
Share
43rd
In South Korea
out of 285 startups
Regional Rank
Share
406th
In East Asia
out of 2082 startups
City Rank
Share
2nd
In Daejeon
out of 14 startups
National Rank
Share
16th
In South Korea
out of 101 startups
Regional Rank
Share
188th
In East Asia
out of 820 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...